Bafna Pharmaceuticals Limited (BAFNAPH.NS)

INR 78.05

(-4.33%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 1.47 Billion 1.29 Billion 902.44 Million 864.65 Million 713.12 Million 1.19 Billion
Total Current Assets 944.69 Million 873.11 Million 513.98 Million 496.68 Million 360.95 Million 484.69 Million
Cash And Short Term Investments 13.96 Million 78.1 Million 194 Thousand 7.47 Million 81.85 Million 1.39 Million
Cash and Cash Equivalents 13.96 Million 78.1 Million 194 Thousand 7.47 Million 81.85 Million 1.39 Million
Short Term Investments 7.01 Million - - - - -
Net Receivables 454.76 Million 416.77 Million 149.33 Million 106.15 Million 134.57 Million 389.32 Million
Inventory 296.41 Million 222.19 Million 202.8 Million 154.43 Million 114.11 Million 92.82 Million
Other Current Assets 179.55 Million 156.04 Million 161.65 Million 228.61 Million 164.98 Million 1.14 Million
Total Non-Current Assets 532.11 Million 422.71 Million 388.45 Million 367.97 Million 352.16 Million 710.03 Million
Net PPE 507.07 Million 402.29 Million 388.45 Million 367.97 Million 351.81 Million 370.19 Million
Good Will And Intangible Assets 17.7 Million 15 Million - - 358 Thousand 358 Thousand
Good Will - - - - 358 Thousand 358 Thousand
Intangible Assets 17.7 Million 15 Million - - - 358 Thousand
Long-Term Investments 7.34 Million - - - - -
Tax Assets -17.7 Million - - - - -
Other Non Current Assets 17.7 Million 5.41 Million -3000.00 -2000.00 -2000.00 339.48 Million
Other Assets - - - - - -
Total Liabilities 652.27 Million 561.28 Million 273.64 Million 296.94 Million 201.17 Million 1 Billion
Total Current Liabilities 540.83 Million 464.76 Million 163.89 Million 243.08 Million 170.99 Million 708.2 Million
Account Payables 354.22 Million 284.6 Million 124.04 Million 106.91 Million 125.41 Million 395.58 Million
Tax Payables - 812 Thousand 899 Thousand 755 Thousand 2.08 Million 21.45 Million
Short Term Debt 136.36 Million 144.9 Million 11.5 Million 105 Million -25.09 Million 232.39 Million
Deferred Revenue 1.62 Million 14.05 Million 6.85 Million 9.67 Million 25.09 Million 33.98 Million
Other Current Liabilities 48.62 Million 21.2 Million 21.49 Million 21.49 Million 45.58 Million 46.23 Million
Total Non Current Liabilities 111.44 Million 96.52 Million 109.74 Million 53.86 Million 30.17 Million 297.99 Million
Long-Term Debt 107.53 Million 84.33 Million 78.92 Million 52.86 Million 30.17 Million 229.88 Million
Deferred Revenue Non Current 16.14 Million 12.19 Million 8.51 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.91 Million -84.33 Million 30.82 Million 1 Million -30.17 Million 6.32 Million
Other Liabilities 1.00 - - - - -
Total Equity 808.39 Million 734.54 Million 628.8 Million 567.71 Million 511.95 Million 188.52 Million
Stock Holders Equity 808.39 Million 734.54 Million 628.8 Million 567.71 Million 511.14 Million 190.58 Million
Common Stock 236.56 Million 236.56 Million 236.56 Million 236.56 Million 23.65 Million 236.56 Million
Retained Earnings -470.99 Million -544.83 Million -660.15 Million -711.66 Million -781.81 Million -534.52 Million
Accumulated other comprehensive income 289.05 Million 289.04 Million 289.04 Million 289.04 Million -391.21 Million -430.51 Million
Common Stock Equity 808.39 Million 734.54 Million 628.8 Million 567.71 Million 511.14 Million 190.58 Million
Capital Lease Obligation - - - - - -
Total Investments 7.34 Million 5.41 Million - - - -
Total Debt 243.89 Million 229.23 Million 90.42 Million 157.86 Million 30.17 Million 462.27 Million
Net Debt 229.93 Million 151.13 Million 90.23 Million 150.38 Million -51.67 Million 460.88 Million

Balance Sheet Charts